BSECompany Update3 Nov 2026 · 3 Nov 2026, 07:20 pm

Please find attached herewith a copy of News Release that is being issued by the Company today.

Bayer CropScience Ltd · 506285

✦ AI SummaryResults

Bayer CropScience Limited reported its unaudited results for Q2 and H1 ended September 30, 2026, with revenue from operations declining 19% and 11% respectively, and profit before tax increasing 6% and 15% respectively.

Analysis Scores

Earnings Impact4/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact6/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Bayer CropScience Ltd - 506285 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Attachments (1)

📄

856f0d7e-be06-44de-adf2-0ea023a56d6d.pdf

pdf

Download →
View document text
November 03, 2026 The General Manager Department of Corporate Services BSE Limited Phiroze Jeejeebhoy Towers Dalal Street Mumbai – 400 001 COMPANY CODE : BAYERCROP SCRIP CODE : 506285 Dear Sir / Madam, Bayer CropScience Ltd. CIN: L24210MH1958PLC011173 Sub.: News Release - Unaudited Financial Results for the quarter and Registered and Corporate Office: half year ended on September 30, 2026. Bayer House Central Avenue Hiranandani Estate We send herewith a copy of the News Release that is being issued by the Thane (West) – 400 607 Company today, in connection with the captioned subject. Maharashtra, India Tel : +91 22 2531 1234 You are requested to kindly take note of the same. Fax : +91 22 2545 5063 www.bayer.in www.cropscience.bayer.com Thanking You. Yours faithfully, for Bayer CropScience Limited Bharati Shetty Company Secretary and Compliance Officer (Membership No.: ACS 24199) Encl.: As above RESTRICTED Bayer CropScience Limited Communications Bayer House, Hiranandani Estate Thane (West) - 400607 News Release Maharashtra, India www.bayer.in Quarterly Results Bayer CropScience Limited reports Q2 and H1 Results for FY 2026-27  Revenue from Operations of ₹12,507 million  Profit Before Tax of ₹2,114 million Mumbai, November 03, 2026: Bayer CropScience Limited (BSE: 506285) announced today its unaudited results for the quarter (Q2) and half year (H1) ended September 30, 2026. For Q2 ended September 30, 2026, Bayer CropScience Limited (BCSL) registered Revenue from Operations of ₹12,507 million as compared to ₹15,534 million in the corresponding period of FY 2025- 26, a decline of 19%. Profit Before Tax stood at ₹2,114 million, compared to ₹2,003 million in the corresponding period of the previous financial year, an increase of 6%. For the H1 ended September 30, 2026, BCSL reported Revenue from Operations of ₹30,857 million compared to ₹34,680 million for the corresponding period in FY 2025-26, a decline of 11%. Profit Before Tax for the H1 ended September 30, 2026, stood at ₹6,135 million, compared to ₹5,355 million for the corresponding period in FY 2025-26, an increase of 15%. Commenting on the quarterly results, Simon Wiebusch, Vice Chairman & Managing Director and CEO, BCSL, said, “Q2 reflected a challenging operating environment, with an uneven monsoon affecting sowing patterns and crop protection demand, alongside lower corn acreages. Against this backdrop, we remained focused on disciplined execution, strengthening our portfolio and scaling new innovations. As Indian agriculture navigates increasing volatility, our priority is to help farmers improve productivity and resilience by bringing together innovations and partnerships across the agricultural ecosystem, while building a stronger and more sustainable business for the long term.” Vinit Jindal, Executive Director and Chief Financial Officer, Bayer CropScience Limited, added, “Profit After Tax increased by 9% in Q2 and 13% in H1, supported by improved gross margins reflecting favourable production yields for corn seeds and cost efficiencies. Higher corn seed production volumes, combined with weaker market demand, resulted in increased inventory. Market liquidity pressures led to delayed collections and marginally higher receivables. We remain focused on disciplined working capital management and strengthening cash generation.” The Board of Directors at its meeting held on November 03, 2026, declared an interim dividend of ₹ 90/- per equity share for the financial year ending March 31, 2027, amounting to ₹ 4,045 million. About Bayer Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. In line with its mission, “Health for all, Hunger for none,” the company’s products and services are designed to support efforts to master major challenges presented by a growing and aging global 1 / 2 RESTRICTED population and create value through innovation and growth. The Bayer brand stands for trust, reliability and quality throughout the world. In fiscal 2025, the Group employed around 88,000 people and had sales of 45.6 billion euros. R&D expenses amounted to 5.8 billion euros. For more information, go to www.bayer.com Media Contact Snigdha Vishal Communications, Bayer CropScience Limited E-mail: snigdha.vishal@bayer.com Forward-Looking Statements This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports, which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments. 2 / 2 RESTRICTED